Johnson & Johnson's 3 Most Promising Drugs

There's no bigger or broader a health care firm on the markets than Johnson & Johnson (NYSE: JNJ  ) . This medical giant sells everything from orthopedic devices to bandages, but it's J&J's top-of-the-line pharmaceuticals that get Wall Street really excited. No other industry has the power to delight -- or disappoint -- like the pharmaceutical industry, and for Johnson & Johnson's drug business, it's done more of the former over the past.

With the patent cliff hitting sales across the industry, however, let's take a look ahead. Which of J&J's drugs have the most promise for the future, and which will investors across health care be talking about for years to come? In the video below, Motley Fool contributor Dan Carroll takes you through three of J&J's most exciting young and developing pharmaceuticals -- and what you can expect from these blossoming stars.

Blockbuster drugs play in a high-risk, high-reward game, but the best health care stocks can provide your portfolio rewards for years-or in Johnson & Johnson's case, decades. For a long-term investor, there's nothing better than such a stable, reliable stock at the foundation of your financial freedom. The Motley Fool's special free report "3 Stocks That Will Help You Retire Rich" names specific investment opportunities that could help you build long-term wealth and help you retire well. The Fool also outlines critical wealth-building strategies that every investor should know. Click here to keep reading.

Read/Post Comments (3) | Recommend This Article (12)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 23, 2013, at 4:56 PM, mamuang wrote:

    With all due respect, the announcer might seek the help of a speech therapist. I found it difficult to understand some of the important parts of the message,

  • Report this Comment On August 24, 2013, at 10:18 AM, greyhound44 wrote:

    Anyone with a brain knows that JNJ is heading for a large fall!

  • Report this Comment On August 25, 2013, at 3:08 AM, ibrutinib wrote:

    iBrutinib not iBruNITIB. Please get your English right. Please, do not make a fool out of yourself, Mr. White man.

    -tinib is an English Suffix (pharmacology) tyrosine kinase inhibitor

    Montley The Fool

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2607179, ~/Articles/ArticleHandler.aspx, 9/26/2016 8:46:48 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,094.83 -166.62 -0.91%
S&P 500 2,146.10 -18.59 -0.86%
NASD 5,257.49 -48.26 -0.91%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 4:01 PM
JNJ $117.78 Down -1.03 -0.87%
Johnson and Johnso… CAPS Rating: *****
MDVN $81.42 Down +0.00 +0.00%
Medivation CAPS Rating: ****
MRK $62.15 Down -0.81 -1.29%
Merck and Co. CAPS Rating: ****
PCYC.DL $0.00 Down +0.00 +0.00%